Method for inhibiting growth hormone action

Details Method for inhibiting growth hormone action Method for inhibiting growth hormone action

1998-02-24

2000-05-02

Ulm, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 8, 530399, 530402, 930120, A61K 3827, C07K 1461

Patent

active

060572922

ABSTRACT:
Human growth hormone variants are disclosed having enhanced affinity for the growth hormone receptor. Also disclosed are human growth hormone variants conjugated to one or more chemical groups, such as poly(ethylene glycol), which is believed to prolong the in vivo half-life of the variants.

REFERENCES:
patent: 3853832 (1974-12-01), Li
patent: 3853833 (1974-12-01), Li
patent: 4446235 (1984-05-01), Seeburg
patent: 4665160 (1987-05-01), Seeburg
patent: 4670393 (1987-06-01), Seeburg
patent: 4699897 (1987-10-01), Jones et al.
patent: 4871835 (1989-10-01), Aviv et al.
patent: 4880910 (1989-11-01), de Boer et al.
patent: 4888286 (1989-12-01), Crea
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5534617 (1996-07-01), Cunningham et al.

Affiliated with

Also associated with

Rating

Method for inhibiting growth hormone action does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for inhibiting growth hormone action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting growth hormone action will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1593860